EGF Theramed Health Corp.
TMED
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 13.71% | 7.34% | 19.62% | 12.46% | -6.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.22% | 5.89% | 17.89% | 10.93% | -5.02% |
| Operating Income | -12.22% | -5.89% | -17.89% | -10.93% | 5.02% |
| Income Before Tax | -430.04% | -414.05% | -794.21% | -691.49% | -28.40% |
| Income Tax Expenses | 19,196.77% | 19,196.77% | -- | -- | -- |
| Earnings from Continuing Operations | -611.88% | -594.58% | -1,102.46% | -966.73% | -29.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -35.00% | -64.09% | 63.70% | -17.50% | 58.54% |
| Net Income | -669.05% | -661.58% | -1,186.43% | -1,065.21% | -27.66% |
| EBIT | -12.22% | -5.89% | -17.89% | -10.93% | 5.02% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -666.54% | -655.91% | -1,165.19% | -1,025.42% | -19.25% |
| Normalized Basic EPS | -542.25% | -536.17% | -981.61% | -880.21% | -10.94% |
| EPS Diluted | -666.54% | -655.91% | -1,165.19% | -1,025.42% | -19.25% |
| Normalized Diluted EPS | -542.25% | -536.17% | -981.61% | -880.21% | -10.94% |
| Average Basic Shares Outstanding | 0.67% | 1.16% | 1.66% | 3.43% | 5.03% |
| Average Diluted Shares Outstanding | 0.67% | 1.16% | 1.66% | 3.43% | 5.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |